Skip to main navigation
Go to Cumberland Pharmaceuticals, Inc. homepage
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
Contact
Contact

SEC Filings

Form Description Filer Filing Date View
4 Statement of changes in beneficial ownership of securities JONES JAMES Jan 06, 2026
View HTML
0001087294-26-000006.pdf
0001087294-26-000006.rtf
0001087294-26-000006.xls
4 Statement of changes in beneficial ownership of securities KAZIMI A J Jan 06, 2026
View HTML
0001087294-26-000004.pdf
0001087294-26-000004.rtf
0001087294-26-000004.xls
4 Statement of changes in beneficial ownership of securities Krogulski Kenneth Dec 01, 2025
View HTML
0001087294-25-000025.pdf
0001087294-25-000025.rtf
0001087294-25-000025.xls
4 Statement of changes in beneficial ownership of securities KAZIMI A J Dec 01, 2025
View HTML
0001087294-25-000027.pdf
0001087294-25-000027.rtf
0001087294-25-000027.xls
4 Statement of changes in beneficial ownership of securities JONES JAMES Dec 01, 2025
View HTML
0001490829-25-000007.pdf
0001490829-25-000007.rtf
0001490829-25-000007.xls
4 Statement of changes in beneficial ownership of securities Young Caroline Dec 01, 2025
View HTML
0001087294-25-000029.pdf
0001087294-25-000029.rtf
0001087294-25-000029.xls
8-K Report of unscheduled material events or corporate event Nov 24, 2025
View HTML
0001087294-25-000023.pdf
0001087294-25-000023.rtf
0001087294-25-000023.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q Quarterly report which provides a continuing view of a company's financial position Nov 07, 2025
View HTML
0001087294-25-000020.pdf
0001087294-25-000020.rtf
0001087294-25-000020.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K Report of unscheduled material events or corporate event Nov 04, 2025
View HTML
0001087294-25-000017.pdf
0001087294-25-000017.rtf
0001087294-25-000017.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
4 Statement of changes in beneficial ownership of securities KAZIMI A J Nov 03, 2025
View HTML
0001075050-25-000006.pdf
0001075050-25-000006.rtf
0001075050-25-000006.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
JONES JAMES
Jan 06, 2026
View HTML
0001087294-26-000006.pdf
0001087294-26-000006.rtf
0001087294-26-000006.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
KAZIMI A J
Jan 06, 2026
View HTML
0001087294-26-000004.pdf
0001087294-26-000004.rtf
0001087294-26-000004.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
Krogulski Kenneth
Dec 01, 2025
View HTML
0001087294-25-000025.pdf
0001087294-25-000025.rtf
0001087294-25-000025.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
KAZIMI A J
Dec 01, 2025
View HTML
0001087294-25-000027.pdf
0001087294-25-000027.rtf
0001087294-25-000027.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
JONES JAMES
Dec 01, 2025
View HTML
0001490829-25-000007.pdf
0001490829-25-000007.rtf
0001490829-25-000007.xls
Form: 4
Description: Statement of changes in beneficial ownership of securities
Young Caroline
Dec 01, 2025
View HTML
0001087294-25-000029.pdf
0001087294-25-000029.rtf
0001087294-25-000029.xls
Form: 8-K
Description: Report of unscheduled material events or corporate event
Nov 24, 2025
View HTML
0001087294-25-000023.pdf
0001087294-25-000023.rtf
0001087294-25-000023.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 10-Q
Description: Quarterly report which provides a continuing view of a company's financial position
Nov 07, 2025
View HTML
0001087294-25-000020.pdf
0001087294-25-000020.rtf
0001087294-25-000020.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 8-K
Description: Report of unscheduled material events or corporate event
Nov 04, 2025
View HTML
0001087294-25-000017.pdf
0001087294-25-000017.rtf
0001087294-25-000017.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Form: 4
Description: Statement of changes in beneficial ownership of securities
KAZIMI A J
Nov 03, 2025
View HTML
0001075050-25-000006.pdf
0001075050-25-000006.rtf
0001075050-25-000006.xls
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • …
  • Next page ›
  • Last page »
Displaying 21 - 30 of 430 results

Data provided by Kaleidoscope.

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy
Accessibility Statement
Terms of Use